Article

Comparative Analysis of Molecular Testing Methods for FGFR2 Fusion/Rearrangement in Intrahepatic Cholangiocarcinoma

2023-09-29

Abstract excerpt

<h4>Backgrounds: </h4> Targeted therapies for intrahepatic cholangiocarcinoma (ICC) patients with FGFR2 fusion/rearrangement have shown significant effectiveness. Reliable and efficient testing strategies for detecting FGFR2 fusion/rearrangement are crucial following FDA and NMPA approval. <h4>Methods: </h4> A cohort of 226 cases underwent RNA-based NGS, DNA-based NGS, and break-apart FISH analysis to evaluate FG...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 3f95a4ef-f42e-52c1-bd60-9eea0426e66c
DOI: 10.21203/rs.3.rs-3358998/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Comparative Analysis of Molecular Testing Methods for FGFR2 Fusion/Rearrangement in Intrahepatic CholangiocarcinomaDOI 10.21203/rs.3.rs-3358998/v1Read

FGFR2 fusion/rearrangement analysis in intrahepatic cholangiocarcinoma using DNA/RNA-based NGS and FISHSemantic proximity Read

Oncogenic activation revealed by FGFR2 genetic alterations in intrahepatic cholangiocarcinomasSemantic proximity Read

Genomic architecture of FGFR2 fusions in cholangiocarcinoma and its implication for molecular testingSemantic proximity Read

FGFR2 testing in cholangiocarcinoma: translating molecular studies into clinical practice.Semantic proximity Read

Targeting extracellular and juxtamembrane FGFR2 mutations in chemotherapy-refractory cholangiocarcinomaSemantic proximity Read

Functions of FGFR2 corrupted by translocations in intrahepatic cholangiocarcinoma.Semantic proximity Read

FGFR2 Inhibition in Cholangiocarcinoma.Semantic proximity Read

FGFR2 Extracellular Domain In-Frame Deletions Are Therapeutically Targetable Genomic Alterations That Function as Oncogenic Drivers in CholangiocarcinomaSemantic proximity Read

Molecular Testing for Intrahepatic Cholangiocarcinoma: What, When, How?Semantic proximity Read

Expression of fibroblast growth factor receptor 2 (FGFR2) in combined hepatocellular-cholangiocarcinoma and intrahepatic cholangiocarcinoma: clinicopathological studySemantic proximity Read

Targeted genomic profiling revealed a unique clinical phenotype in intrahepatic cholangiocarcinoma with fibroblast growth factor receptor rearrangementSemantic proximity Read

New Routes to Targeted Therapy of Intrahepatic Cholangiocarcinomas Revealed by Next-Generation SequencingSemantic proximity Read